Member Info for PJT12

Thought you might be interested in this, from Dazpink on HEMO.

AbbVie signs $10 bln deal to buy cancer drugmaker ImmunoGen

https://www.reuters.com/markets/deals/abbvie-buy-immunogen-101-billion-boost-cancer-drug-portfolio-2023-11-30/

Firstly, Hemotruth, can you stop being so obviously negative, spreading your highly transparent seeds of doubt? Although, looking at your history, I guess at least you're consistent. That aside..........

Just looking back at the FDA letter details in the RNS on 10 July, one aspect that pleased me was, "The CH letter also contains several suggestions on how to improve the safety of HEMO-CAR-T. These suggestions do not and would not contribute to the CH and can be dealt with readily."

That not only says the FDA is keen to work with us but also provides them with a sense of ownership in the product through seeing their ideas being adopted by us. That can only improve the chances of them being inclined towards wanting us to succeed in our application.

".....everything I have learned in the past few years has left me disgusted with just how underhand the markets are." Whilst I agree with much of what you say and no offence intended, JustHereForHemo, there are very obvious answers to your post, one of which is, you clearly haven't learnt (any more than the rest of us) or you wouldn't still be here. I agree though,flippin' frustrating and we are too frequently left wondering why the regulators aren't getting their heads out of their ar**s.

Micky, I think you should have included commas after "Woodcot" and "twat" 😉

"ETERNAL verification of manufacturing test run"? I know things can move slowly in this business but now you ARE taking the P***!

Try rebooting your router :-)

I realise that, Pumpky, but the science, relatively small SP movement (on both sides of the pond) and some decent buying volume suggest there is no great concern amongst those far better qualified than us to 'know'.

As somebody whose timing has been blimmin' awful as far as this share's concerned, I'd still defend Stu'. I want to see ALL news that could potentially affect companies I'm invested in. That is surely preferable to sitting here in blind ignorance and the story he posted was covered by just about every major US news org. Unless those criticising him were raised in North Korea, I cannot see why there's a need to condemn him for posting a factual story of relevance.

Stu, you could argue we've already seen how the market's reacted Stateside: Hardly at all.

..........all the words and letters are there, just rearrange them into the correct order :-)

Pumpky, as a fairly new visitor to this board, gotta be honest and say that your accusation of another poster writing "long monotonous posts" is a bit "rich". I certainly find their 'substance' preferable anf far more useful than your sniping 'one liners' - but I guess every board has 'one' and you seem to be it here. As for Stu', I appreciated him posting that news item which was obviously out there for all to see, in the same way others' looked on here looked to provide some knowledgeable balance through their fact based posts which provided equally interesting food for thought.

Https://www.fiercebiotech.com/biotech/volatile-day-car-t-biotechs-after-fda-announces-secondary-cancer-safety-review

://www.fiercebiotech.com/biotech/volatile-day-car-t-biotechs-after-fda-announces-secondary-cancer-safety-review

SP Angel Corporate Finance LLP, as listed on the RNS - see their website: https://www.spangel.co.uk/about/

Shouldn't they be the targets of people's ire here, at least those blaming Vlad for this raise?

In fairness, wouldn't the CEO only be doing what his financial advisors are telling him to go ahead with by way of required fund raising? Isn't that what the company's paying them for? He's a scientist rather than a financier. The Avacta CEO did exactly the same thing in earlier days......."No fund raise"......which they then did!

In fairness, wouldn't the CEO only be doing what his financial advisors are telling him to go ahead with by way of required fund raising? Isn't that what the company's paying them for? He's a scientist rather than a financier. The Avacta CEO did exactly the same thing in earlier days......."No fund raise"......which they then did!

Well done to all the LTH's here, Dickupham especially. Patience clearly is a virtue and glad to see it's paid off for the faithful here. Also, well done to the BoD who've enabled this.

Thx but no thx.

Roger, go and listen to Kenny Roger's The Gambler.....again. It ain't like the red flags haven't been evident here for yonks.

Hate to say it but if ever there was a case of "jam tomorrow" then this ongoing saga appears to be it. Such a shame when I think back to the days of so much hope prior to FDA Parsortix approval.